Co-Diagnostics股价上涨11%，私下筹集300万美元

• Co-Diagnostics (CODX) announced a private placement agreement with institutional investors to sell 1.65M shares of common stock, or pre-funded warrants in lieu of shares, along with warrants to purchase up to 3.29M additional shares.
• The accompanying warrants carry an exercise price of $1.571 per share, are exercisable immediately and expire after five years.
• The gross proceeds are estimated to be ~$3M.
• The offering is expected to close on or about May 21, 2026.
• The stock price jumped about 11% on Tuesday during after-market hours of trading.

More on Co-Diagnostics

• Co-Diagnostics, Inc. (CODX) Q1 2026 Earnings Call Transcript
• Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript
• Co-Diagnostics anticipates filing FDA 510(k) in the third quarter as CoSara expands TAM to approximately $13B
• Co-Diagnostics GAAP EPS of -$4.06 misses by $0.31, revenue of $0.15M misses by $0.01M
• Seeking Alpha’s Quant Rating on Co-Diagnostics